Immunization of Alpacas with HIV-1 Env Trimers to Develop Broadly Neutralizing Nanobodies Targeting CD4 Binding Site
Closed Pre-Solicitation Posted
- Solicitation number
- NOI-NIAID-23-2182229
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate a non-competitive contract with Capralogics Inc. for an animal study comparing two immunization protocols in Alpacas, a continuation of studies that began in 2007. The services include providing and maintaining the animals, performing immunizations and blood screenings, and collecting, isolating, storing, and shipping Peripheral Blood Mononuclear Cells (PBMC’s). The contract is subject to various certifications and regulations, and interested parties may submit a capability statement by August 17th, 2023.
Services to be provided by the contractor:
- Providing and maintaining the animals for the study.
- Performing the immunizations as per the protocol.
- Performing blood screenings at specific times.
- Collection, isolation, storage, and shipping of Peripheral Blood Mononuclear Cells (PBMC’s).
- Compliance with all required licenses/certifications.
Notice text
This is a Notice of Intent, not a request for competitive quotation. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Capralogics Inc. for an animal study to compare the efficiency of two immunization protocols in Alpacas. These studies began in 2007, and this procurement is to continue the protocol testing services.
The North American Industry Classification System (NAICS) code for this requirement is 541380 - Laboratories and Services.; the business standard is $19,000,00 Product Service Code (PSC) Q301 Medical laboratory Testing.
The testing services will include:
- Providing the Animals with guarantee of only our contract use.
- Animal maintenance (i.e., housing, cleaning, feed, veterinary care)
- Performing the immunizations per protocol
- Performing blood screening throughout the service at specific times
- Collection, Isolation, storage, and shipping ability of Peripheral Blood Mononuclear Cells (PBMC’s) at specified quantities, both internationally and domestically.
- Must have all required licenses/certifications:
- USDA licensed.
- Must be an approved NIH research facility and provide the Animal Assurance Identification number.
- Must be approved under EC Regulation 1069/2009 (European Parliament) as an Approved Blood Collection Facility with approvals to export untreated animal serums and plasma.
The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. Sources interested in responding to this notice are required to submit a capability statement that includes a copy of all the required certifications listed above, and in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required services. Capability statements shall not exceed 3 (8.5” x 11”) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2182229) to Laura Grey at laura.grey@nih.gov, by 1:00 pm eastern standard time Thursday, August 17th, 2023.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| NAHLN Diagnostic Testing Services | Marketing and Regulatory Programs Business Services | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity